Navigation Links
Testosterone levels could serve as a marker for determining risk of SIDS

A recent study conducted on the Sudden Infant Death Syndrome (SIDS) has found out that nearly all cases are associated with an increase in testosterone levels. Testosterone is a male sex hormone. //The levels are considerably higher in infants who have died suddenly from SIDS than in infants who have died suddenly from other causes.

Researchers from the University of Washington compared hormone levels in blood collected from 169 infants who had died of SIDS and 42 who died of other causes. A significant elevation of the male hormone levels were found in the cases studied. In contrast, levels of estradiol, an estrogen-type hormone, did not differ significantly between SIDS victims and the control group.

SIDS is the sudden and unexplained death of an infant. It is the leading cause of death among infants who are 1 month to 1 year old. SIDS should be diagnosed only when all other possible causes of death have been ruled out by a detailed evaluation of the medical history. There is no specific symptom to diagnose the condition

Previous studies have already hinted the possibility of a link between SIDS and sex hormone levels, such as the correlation between the rise in sex hormone levels and the age range of risk for SIDS. Moreover, testosterone levels have also been implicated in a number of sleep disorders associated with breathing difficulties in adults. Any alteration in the levels of the sex hormones (testosterone and estrogen) can affect the nerve structure and function in older and younger male and female animals. More importantly, any increase in these levels following birth can result in a compromise involving the nervous system in otherwise-normal infants.

In conclusion, further research is needed to determine whether testosterone is abnormal in living infants at risk for SIDS and to determine the value of monitoring testosterone or related hormones to identify those infants at increased risk of SIDS.
'"/>




Page: 1

Related medicine news :

1. Testosterone Replacement Therapy Safe If Monitored Appropriately
2. Low Testosterone Levels the Cause Of Depression In Men
3. The Use Of Testosterone Replacement Therapy Questioned
4. Depression In Men Could Be To Low Testosterone Levels
5. Testosterone patch for women Rejected For safety Reasons
6. Testosterone Patches Found To Increase Sexual Desire In Menopausal Women
7. Testosterone Therapy can improve sexual function in postmenopausal women
8. Fatherhood Found To Tame Men by Reducing Testosterone Levels
9. Males Lifespan Shortened By Elevated Levels Of Testosterone
10. Study Indicates An Increased Risk Of Breast Cancer In Women Undertaking Estrogen and Testosterone Therapy
11. Low Testosterone Linked With Early Death
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... Healthcare ... The Medical Center at Craig Ranch building at 8080 State Highway 121, Suite 210, ... District with easy access to Highway 121. , As the practice has grown, the ...
(Date:2/24/2017)... ... 2017 , ... The International Association of Eating Disorders Professionals (iaedp) announces the ... body image mannequin art competition. Selected from 15 submissions from around the nation, the ... the 31st annual iaedp Symposium, March 22 – 26 in Las Vegas. , This ...
(Date:2/24/2017)... ... February 24, 2017 , ... Castle Farms, ... their Military Wedding Giveaway, with the winning couple announced on Feb. 14, 2017, ... generously donated from local vendors: A Matter of Taste, Ryan Rousseau Enterprises, A ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... a clinician-based audience, will be participating in Rare Disease Day events, hosted by ... In addition, Rare Disease Report, a website, weekly e-newsletter and quarterly publication, will ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... for the National Institute for Health and Care Excellence (NICE) framework. ... the National Health Service (NHS) to search, order and purchase medical and healthcare-related ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... CHEYENNE, Wyoming , Feb. 24, 2017  Xynomic ... company, today announced that it has acquired exclusive ... a potentially best-in-class innovative HDAC inhibitor targeting hematological ... total of 14 Phase 1 and 2 clinical ... Asia have already been completed, ...
(Date:2/23/2017)... -- Research and Markets has announced the addition of ... 2016" report to their offering. ... The latest research Autism Spectrum Disorder Drugs ... benchmarks in the global Autism Spectrum Disorder market. The research ... the key drugs marketed for Autism Spectrum Disorder and their clinical ...
(Date:2/23/2017)... -- Cogentix Medical, Inc. (NASDAQ: CGNT), a medical device company ... the urology market, will release financial results for the ... before the market open on Thursday, March 9, 2017. ... call and webcast to discuss its financial results the ... a.m. Eastern Time (10:00 a.m. Central Time). Darin ...
Breaking Medicine Technology: